105 related articles for article (PubMed ID: 12115874)
1. Progressive loss of PAX9 expression correlates with increasing malignancy of dysplastic and cancerous epithelium of the human oesophagus.
Gerber JK; Richter T; Kremmer E; Adamski J; Höfler H; Balling R; Peters H
J Pathol; 2002 Jul; 197(3):293-7. PubMed ID: 12115874
[TBL] [Abstract][Full Text] [Related]
2. p53 gene mutants expression, cellular proliferation and differentiation in oesophageal carcinoma and non-cancerous epithelium.
Jaskiewicz K; De Groot KM
Anticancer Res; 1994; 14(1A):137-40. PubMed ID: 8166440
[TBL] [Abstract][Full Text] [Related]
3. Loss of MAL expression in precancerous lesions of the esophagus.
Mimori K; Nishida K; Nakamura Y; Ieta K; Yoshikawa Y; Sasaki A; Ishii H; Alonso MA; Mori M
Ann Surg Oncol; 2007 May; 14(5):1670-7. PubMed ID: 17151798
[TBL] [Abstract][Full Text] [Related]
4. [Quantitative study on esophageal cytology. II. Measurement of DNA contents of normal, dysplastic and malignant squamous cells of the esophagus].
Xiang YY
Zhonghua Zhong Liu Za Zhi; 1990 Sep; 12(5):342-4. PubMed ID: 2276324
[TBL] [Abstract][Full Text] [Related]
5. Three isoforms of annexin I are preferentially expressed in normal esophageal epithelia but down-regulated in esophageal squamous cell carcinomas.
Xia SH; Hu LP; Hu H; Ying WT; Xu X; Cai Y; Han YL; Chen BS; Wei F; Qian XH; Cai YY; Shen Y; Wu M; Wang MR
Oncogene; 2002 Sep; 21(43):6641-8. PubMed ID: 12242662
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic switch occurs during the precancerous stage of human esophageal squamous cell carcinoma.
Kitadai Y; Onogawa S; Kuwai T; Matsumura S; Hamada H; Ito M; Tanaka S; Yoshihara M; Chayama K
Oncol Rep; 2004 Feb; 11(2):315-9. PubMed ID: 14719061
[TBL] [Abstract][Full Text] [Related]
7. Pax9 is required for filiform papilla development and suppresses skin-specific differentiation of the mammalian tongue epithelium.
Jonker L; Kist R; Aw A; Wappler I; Peters H
Mech Dev; 2004 Nov; 121(11):1313-22. PubMed ID: 15454262
[TBL] [Abstract][Full Text] [Related]
8. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
9. Expression of human telomerase reverse transcriptase mRNA in esophageal cancers and precancerous lesions.
Amioka T; Kitadai Y; Hiyama T; Tanaka S; Yoshihara M; Haruma K; Chayama K
Oncol Rep; 2004 Jan; 11(1):51-5. PubMed ID: 14654902
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
[TBL] [Abstract][Full Text] [Related]
11. PAX9 regulates squamous cell differentiation and carcinogenesis in the oro-oesophageal epithelium.
Xiong Z; Ren S; Chen H; Liu Y; Huang C; Zhang YL; Odera JO; Chen T; Kist R; Peters H; Garman K; Sun Z; Chen X
J Pathol; 2018 Feb; 244(2):164-175. PubMed ID: 29055049
[TBL] [Abstract][Full Text] [Related]
12. [Dysregulation of Annexin II expression in esophageal squamous cell cancer and adjacent tissues from a high-incidence area for esophageal cancer in Henan province].
Qi YJ; Wang LD; Jiao XY; Feng XS; Fan ZM; Gao SS; He X; Li JL; Chang FB
Ai Zheng; 2007 Jul; 26(7):730-6. PubMed ID: 17626749
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
[TBL] [Abstract][Full Text] [Related]
14. Studies on Pax9-Msx1 protein interactions.
Ogawa T; Kapadia H; Wang B; D'Souza RN
Arch Oral Biol; 2005 Feb; 50(2):141-5. PubMed ID: 15721141
[TBL] [Abstract][Full Text] [Related]
15. [Demonstration of an epidermal SH-protease inhibitor in normal epithelium and in some human neoplasms--an immunological study (author's transl)].
Rinne A; Järvinen M; Räsänen O; Dorn A
Acta Histochem Suppl; 1980; 22():325-9. PubMed ID: 6789389
[TBL] [Abstract][Full Text] [Related]
16. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
17. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
18. Anomalous expression of epithelial differentiation-determining GATA factors in ovarian tumorigenesis.
Capo-chichi CD; Roland IH; Vanderveer L; Bao R; Yamagata T; Hirai H; Cohen C; Hamilton TC; Godwin AK; Xu XX
Cancer Res; 2003 Aug; 63(16):4967-77. PubMed ID: 12941822
[TBL] [Abstract][Full Text] [Related]
19. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
[TBL] [Abstract][Full Text] [Related]
20. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
